Literature DB >> 96085

Disc agar diffusion antimicrobial susceptibility tests with beta-lactamase producing Neisseria gonorrhoeae.

J W Biddle, J M Swenson, C Thornsberry.   

Abstract

The emergence of beta-lactamase-producing strains of Neisseria gonorrhoeae has led to a reexamination of the role of the disc agar diffusion method in susceptibility testing of gonococci. Our data show that the disc agar diffusion test can be used to screen for beta-lactamase production by these organisms. The disc tests were done on GC Agar Base supplemented with 1% IsoVitaleX. An inoculum of 10(8) colony forming units/ml and either a 10-unit-penicillin or a 10-microgram-ampicillin disc were used. A zone diameter of less than or equal to 19 mm was indicative of beta-lactamase production. These results were compared with results of chemical tests for beta-lactamase and with minimal inhibitory concentrations. Recommondations were also made for a disc test with tetracycline and spectinomycin, but these methods must remain tentative because of the lack of resistant strains.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96085     DOI: 10.7164/antibiotics.31.352

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

1.  High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant.

Authors:  S A Morse; S R Johnson; J W Biddle; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Tetracycline-resistant Neisseria gonorrhoeae.

Authors:  T J Papadimos; R A Batchelor; E M Lane; J W Biddle; J M Zenilman
Journal:  West J Med       Date:  1986-09

3.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.

Authors:  I Luman; R W Wilson; R J Wallace; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 4.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System.

Authors:  C N Baker; C Thornsberry; R W Hawkinson
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

6.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.

Authors:  R N Jones; T L Gavan; C Thornsberry; P C Fuchs; E H Gerlach; J S Knapp; P Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

Authors:  J M Miller; C N Baker; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae.

Authors:  M A Shapiro; C L Heifetz; J C Sesnie
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

10.  Cefuroxime, thiamphenicol, spectinomycin, and penicillin G in uncomplicated infections due to penicillinase-producing strains of Neisseria gonorrhoeae.

Authors:  T E Tupasi; L B Crisologo; C A Torres; O V Calubiran; I de Jesus
Journal:  Br J Vener Dis       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.